InvestorsObserver
Sign Up Login

ATHX Athersys Inc

$0.25 $0.00 (0.00%)
Add to Watchlist Compare
Overall

ATHX Stock Analysis Overview

What this means: InvestorsObserver gives Athersys Inc (ATHX) an overall rank of 34, which is below average. Athersys Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

ATHX Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

ATHX Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

ATHX Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

ATHX Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

ATHX Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

ATHX Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

ATHX Stock Analysis Overview

What this means: InvestorsObserver gives Athersys Inc (ATHX) an overall rank of 34, which is below average. Athersys Inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 34 means that 66% of stocks appear more favorable to our system.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full ATHX report

ATHX Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

ATHX Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

ATHX Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

ATHX Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

ATHX Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

ATHX Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Athersys Inc (ATHX) Analyst Forecast

ATHX Price, Volume, Earnings, and Dividend Date

  • Last Price $0.25
  • Previous Close $0.25
  • Change $0.00
  • Open $0.25
  • Volume 7,380,900
  • Avg. Volume (100-day) 9,667,991
  • Market Cap 66,194,586
  • Days Range 0.2422 - 0.2595
  • 52-week Range 0.17 - 1.81
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS —
  • Earnings Date 11/09/22
  • Sector Healthcare
  • Industry Biotechnology
  • Avg. Analyst Rec. Premium
  • Beta 2.530
  • PEG Ratio —

Athersys Inc (ATHX) Company Description

Athersys Inc is a biotechnology company. It is focused on developing novel and proprietary therapies in the areas where there is an unmet medical need, particularly in the regenerative medicine area. The firm's main product is Multistem cell therapy. Its current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.

Athersys Inc (ATHX) Stock Chart

View Interactive ATHX chart

My Watchlists

Follow Your Favorite Stocks

Top Stocks in Biotechnology

Company Price
Arcutis Biotherapeutics Inc (ARQT) (ARQT) $24.72
Trevi Therapeutics Inc (TRVI) (TRVI) $3.78
Savara Inc (SVRA) (SVRA) $1.68
G1 Therapeutics Inc (GTHX) (GTHX) $13.10
Soligenix Inc (SNGX) (SNGX) $0.87
Verona Pharma Plc ADR (VRNA) (VRNA) $12.48
Pliant Therapeutics Inc (PLRX) (PLRX) $21.71
Axsome Thera (AXSM) (AXSM) $47.37
Concert Pharmaceutic (CNCE) (CNCE) $6.92
Satsuma Pharmaceuticals Inc (STSA) (STSA) $5.88